<DOC>
	<DOCNO>NCT00463359</DOCNO>
	<brief_summary>The purpose study determine recurrence rate nodular Basal Cell Carcinomas face remove curettage electrodessication ( cautery ) follow application Imiquimod cream base achieve low recurrence rate treatment curettage electrodessication alone .</brief_summary>
	<brief_title>A Pilot Study Treatment Facial Nodular Nodulocystic Basal Cell Carcinoma With Double Curettage Cautery Followed Application Imiquimod Base</brief_title>
	<detailed_description>Basal Cell Carcinomas ( BCC ) common form skin cancer white population . The face frequently occur nodular BCCs common type . Curettage cautery/electrodessication ( C &amp; C ) establish way management nodular BCCs year , simple surgical procedure readily perform outpatient clinic good aesthetic result high cure rate . The purpose study determine recurrence rate nodular BCCs face remove C &amp; C follow application Imiquimod cream base achieve low recurrence rate treatment C &amp; C alone . Imiquimod immune response modifier anti-tumour effect already license treatment superficial BCCs UK .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>Welldefined primary , previously treat nodulocystic BCC Size lesion : â‰¤ 1cm diameter Facial lesion Patient compliance competent Patient physically able apply treatment ( cream ) Recurrent lesion Superficial , morphoeic pigment BCC Lesions close vital structure ; i.e . C &amp; C consider standard treatment ( eyelid , inner canthus , free border ) Lesions within 1 cm eyelid , nose , lip hairline Immunosuppressed patient Women childbearing age , pregnancy breastfeeding Ages &lt; 50 &gt; 90 Patients compliance incompetent Patients physically incapable apply treatment ( cream ) Patients Gorlin Syndrome ( nevoid Basal Cell Carcinoma syndrome )</criteria>
	<gender>All</gender>
	<minimum_age>49 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>basal cell carcinoma</keyword>
	<keyword>curettage</keyword>
	<keyword>Imiquimod</keyword>
	<keyword>treatment</keyword>
</DOC>